Your session is about to expire
← Back to Search
MOTO Medial® UKA for Knee Arthritis
Study Summary
This trial will study the long-term performance of a new type of knee surgery, comparing patient reports, clinical findings, and x-rays.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently pregnant.I have had knee replacement surgery on the knee we are discussing.I can follow the study's requirements and attend all visits.I am 18 years old or older.You regularly take strong pain medications (like opioids) before surgery.My knee ligament is unstable.I have had a knee infection in the past.I am currently receiving chemotherapy or radiation for cancer.My knee condition matches the FDA guidelines for MOTO Medial® UKA use.I have never had joint replacement surgery on the affected knee.I can attend follow-up appointments and am mentally capable of participating in the study.You have had an allergic reaction or sensitivity to materials used in orthopedic implants like Titanium and Cobalt-Chrome alloys.I have a metabolic disorder affecting my bones, not including osteoarthritis or osteoporosis.My knee condition matches the FDA guidelines for MOTO Medial® UKA use.I am currently taking medications that suppress my immune system, including steroids.You have a mental health condition.I have inflammatory arthritis.I have long-term pain not related to my knee.You have a history of alcoholism or drug addiction.I have had surgery to realign my knee.
- Group 1: Interventional : MOTO Medial® UKA
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment still available in this clinical research study?
"According to clinicaltrials.gov, registration for this medical study has been closed since March 29th of 2022. Nevertheless, there are currently 708 other trials seeking volunteers across the globe."
What results is this trial intended to yield?
"The primary outcome of this medical trial will be the Forgotten Joint Score, which patients are assessed on at Baseline and 4-8 months post-surgery, 9-15 months, 18-30 and 51-69. Additionally, researchers will gauge Return to Work/Activity questionnaire scores (assessing ability to return to work or other activities), K & L Grading levels (OA Disease Grade in knee compartment) as well as Anesthetic type used during surgery."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger